Healthcare Robotics Market by Product Type (Diagnostic & Imaging Robots, Noninvasive-Radiosurgery Robotic Systems, Pharmacy & Laboratory Robotics), Technology (Artificial Intelligence, Augmented Reality, Internet of Things (IoT)), Application, End-User -
Description
The Healthcare Robotics Market was valued at USD 15.84 billion in 2024 and is projected to grow to USD 17.33 billion in 2025, with a CAGR of 9.91%, reaching USD 33.73 billion by 2032.
Exploring the Emergence of Healthcare Robotics and Its Pivotal Role in Revolutionizing Patient Treatment Protocols and Operational Workflows
Over the past decade, healthcare robotics has transcended academic laboratories to become an integral component of modern medical practice. Fueled by dramatic advancements in artificial intelligence, machine learning, and precision engineering, robotic systems now support a wide array of clinical procedures, from minimally invasive surgery to patient rehabilitation. This introduction outlines the technological foundations and evolving landscape that position robotics as a catalyst for improved patient outcomes, operational efficiency, and cost containment in healthcare settings.
As patient populations grow and age, and as healthcare providers face workforce shortages and heightened demand for quality care, robotics emerge as a strategic solution. This section sets the stage for understanding how integrated robotic platforms are redefining traditional protocols, enabling remote interventions, and enhancing surgeon dexterity through augmented reality and haptic feedback. With regulatory bodies increasingly recognizing the safety and efficacy of robotic interventions, the deployment of these systems is accelerating across hospitals, clinics, and specialty centers, charting a new era in clinical innovation.
Analyzing the Transformative Shifts Shaping the Healthcare Robotics Landscape with Advances in AI, Connectivity, and Regulatory Adaptations
Healthcare robotics has undergone a series of transformative shifts that extend well beyond incremental improvements. The convergence of advanced artificial intelligence and machine learning algorithms has endowed robotic platforms with predictive capabilities, enabling real-time decision support during complex procedures. Simultaneously, the proliferation of Internet of Things connectivity has fostered seamless integration between robotic units and hospital information systems, creating a data-rich ecosystem for continuous performance optimization.
Moreover, augmented reality tools are evolving from niche applications in surgical training to immersive interfaces for patient engagement and intraoperative guidance. On the policy front, evolving reimbursement models and clearer regulatory pathways have incentivized adoption by reducing financial and compliance uncertainties. Together, these shifts are redefining the competitive landscape, forcing stakeholders to reassess R&D priorities, forge novel partnerships, and recalibrate go-to-market strategies in response to a market driven by agility and collaboration.
Evaluating the Cumulative Effects of the 2025 United States Tariffs on Healthcare Robotics Procurement, Supply Chains, and Cost Structures Across the Industry
The implementation of United States tariffs in 2025 has imposed new cost pressures across the healthcare robotics supply chain, compelling manufacturers and end users to reevaluate procurement strategies. Components sourced from overseas, particularly from established technology hubs, now face elevated duties, inflating capital expenditure for advanced robotic suites and peripheral devices. In response, strategic sourcing and component localization have become critical for mitigating tariff-driven price adjustments and maintaining accessible pricing structures for healthcare providers.
These trade policies have also catalyzed innovation in logistics and inventory management, as companies seek to optimize just-in-time delivery and buffer stock levels to offset potential disruptions. As a result, cross-border alliances and regional manufacturing partnerships have accelerated, underpinning a shift toward more resilient, diversified distribution networks. Stakeholders prioritizing supply chain adaptability and transparent cost modeling will be best positioned to navigate the ongoing impact of tariff regimes on procurement cycles and capital budgeting.
Unraveling Key Segmentation Perspectives by Product, Technology, Application, and End-User with Strategic Insights into Market Dynamics
A comprehensive understanding of the healthcare robotics market demands examination through multiple segmentation lenses. When assessed by product type, diagnostic & imaging robots, noninvasive-radiosurgery robotic systems, pharmacy & laboratory robotics, rehabilitation robotic systems-further subdivided into assistive robotic systems, exoskeleton robotic systems, and therapeutic robotic systems-service & logistics robots, and surgical robots emerge as critical categories that address distinct clinical workflows and service models. This product orientation reveals precise adoption corridors and highlights areas where technological convergence is fostering new capabilities.
From a technology standpoint, artificial intelligence and machine learning form the backbone of intelligent automation, while the Internet of Things establishes interconnected platforms for device monitoring and performance analytics. Augmented reality applications, including patient engagement AR and surgical training AR, are unlocking interactive training and preoperative planning experiences. Evaluating applications across cardiology, laparoscopy, neurology, and orthopedics highlights specialized use cases driving investment in niche segments. Finally, end-user segmentation encompassing hospitals & clinics, rehabilitation centers, and surgical centers-further detailed into ambulatory surgery centers and day surgery centers-demonstrates the diverse operational settings influencing purchasing priorities and service delivery models.
Decoding Regional Variations in Healthcare Robotics Adoption and Growth across Americas, Europe Middle East Africa, and Asia-Pacific Markets
Geographic dynamics play a pivotal role in the adoption and maturation of healthcare robotics. In the Americas, advanced reimbursement frameworks and robust private-public partnerships are accelerating deployment in tertiary care and specialized surgical centers. This region’s emphasis on precision medicine and patient safety drives continued investment in integrated robotic solutions, while digital health initiatives foster interoperability and tele-robotic capabilities.
Across Europe, the Middle East, and Africa, heterogeneous regulatory environments and diverse economic conditions have shaped a multifaceted adoption curve. Western Europe’s established healthcare infrastructure sustains high uptake of surgical and diagnostic robots, whereas emerging economies in the Middle East and Africa prioritize cost-effective rehabilitation and logistics automation to address workforce deficits. In the Asia-Pacific region, proactive government policies, large patient populations, and growing domestic manufacturing capacity are fueling rapid expansion, particularly in minimally invasive surgery and rehabilitative care. These regional insights underscore the necessity for adaptable go-to-market frameworks that respect local regulations and healthcare delivery models.
Highlighting Leading Companies and Their Strategic Initiatives Driving Innovation, Partnerships, and Competitive Positioning in Healthcare Robotics
Leading companies in the healthcare robotics field are distinguishing themselves through strategic R&D investments, targeted acquisitions, and collaborative ventures. One prominent developer has leveraged its core surgical robotics platform to deliver advanced instrumentation and data analytics capabilities, establishing a singular position in high-volume operating rooms. Another diversified technology firm has integrated pharmacy automation with artificial intelligence-driven inventory management, streamlining medication dispensing and reducing manual errors.
Strategic partnerships between robotics innovators and software developers are accelerating the deployment of cloud-based control systems and predictive maintenance tools. In parallel, new entrants with expertise in exoskeleton design are forging alliances with rehabilitation centers to co-develop patient-centric solutions. This mosaic of collaboration, coupled with a focus on intellectual property expansion and clinical validation studies, is intensifying competition and shaping a landscape in which innovation speed and ecosystem integration are decisive differentiators.
Formulating Actionable Strategies and Expert Recommendations to Navigate Challenges and Capitalize on Opportunities in Healthcare Robotics
Industry leaders must pursue multifaceted strategies to harness the full potential of healthcare robotics. Prioritizing interoperability standards and open architectures will enable seamless integration of new robotic modules with existing hospital systems, minimizing implementation friction and accelerating clinical adoption. Additionally, investing in advanced workforce training programs that blend hands-on robotic operation with immersive augmented reality simulations can reduce the learning curve for surgical teams and rehabilitation specialists.
Regulatory engagement is another critical dimension: proactive collaboration with health authorities to establish clear safety guidelines and reimbursement pathways will unlock broader market access. To mitigate geopolitical and supply chain risks, companies should diversify component sourcing and explore local manufacturing partnerships, thereby enhancing supply resilience and cost predictability. Finally, forging cross-sector alliances with data analytics providers, telehealth platforms, and patient advocacy groups will expand value propositions and address evolving care delivery models, positioning stakeholders to capitalize on emerging growth opportunities.
Outline of Rigorous Research Methodology and Analytical Framework Employed to Ensure Credibility and Depth in Healthcare Robotics Market Insights
This analysis draws on a robust, multi-stage research methodology designed to ensure credibility, depth, and relevance. Initially, secondary research encompassed peer-reviewed journals, clinical trial registries, patent filings, and publicly available regulatory guidance to establish foundational context and identify prevailing technology trends. Subsequently, primary research was conducted through structured interviews with key opinion leaders, including surgeons, rehabilitation specialists, supply chain executives, and healthcare policymakers, providing firsthand perspectives on adoption drivers and constraints.
Data triangulation was applied by cross-referencing secondary sources with insights from industry participants, while top-down and bottom-up analytical techniques elucidated market and segment dynamics. Quantitative data sets were validated against real-world case studies, ensuring alignment between theoretical projections and practical implementations. This integrated approach culminates in an analytical framework that rigorously examines technological, regulatory, and operational dimensions of the healthcare robotics space.
Concluding Reflections on the Ongoing Transformation in Healthcare Robotics and the Imperative Next Steps for Industry Stakeholders to Drive Progress
The healthcare robotics industry stands at an inflection point, poised to deliver transformative benefits across surgical, diagnostic, and rehabilitative domains. Converging technological advancements in artificial intelligence, connectivity, and immersive interfaces are redefining clinical best practices, while evolving reimbursement and regulatory landscapes are lowering barriers to entry. Going forward, stakeholders must embrace collaborative innovation, supply chain agility, and workforce readiness to maintain momentum.
The path ahead will be shaped by an ongoing dialogue among manufacturers, providers, regulators, and patients, each contributing unique insights to refine safety standards, expand application scopes, and ensure equitable access. By fostering an ecosystem that balances rapid technological progress with rigorous validation and ethical considerations, industry participants can collectively drive enhanced quality of care, operational efficiency, and patient satisfaction. This conclusion underscores the importance of strategic alignment and continuous adaptation as the healthcare robotics field enters its next phase.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Product Type
Diagnostic & Imaging Robots
Noninvasive-Radiosurgery Robotic Systems
Pharmacy & Laboratory Robotics
Rehabilitation Robotic Systems
Assistive Robotic Systems
Exoskeleton Robotic Systems
Therapeutic Robotic Systems
Service & Logistics Robots
Surgical Robots
Technology
Artificial Intelligence
Augmented Reality
Patient Engagement AR
Surgical Training AR
Internet of Things (IoT)
Machine Learning
Application
Cardiology
Laparoscopy
Neurology
Orthopedics
End-User
Hospitals & Clinics
Rehabilitation Centers
Surgical Centers
Ambulatory Surgery Centers
Day Surgery Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Asensus Surgical US, Inc.
FANUC Corporation
Intuitive Surgical, Inc.
Johnson & Johnson Services, Inc.
Medtronic Plc
Parker Hannifin Corporation
Robocath SA
Siemens AG
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Please Note: PDF & Excel + Online Access - 1 Year
Exploring the Emergence of Healthcare Robotics and Its Pivotal Role in Revolutionizing Patient Treatment Protocols and Operational Workflows
Over the past decade, healthcare robotics has transcended academic laboratories to become an integral component of modern medical practice. Fueled by dramatic advancements in artificial intelligence, machine learning, and precision engineering, robotic systems now support a wide array of clinical procedures, from minimally invasive surgery to patient rehabilitation. This introduction outlines the technological foundations and evolving landscape that position robotics as a catalyst for improved patient outcomes, operational efficiency, and cost containment in healthcare settings.
As patient populations grow and age, and as healthcare providers face workforce shortages and heightened demand for quality care, robotics emerge as a strategic solution. This section sets the stage for understanding how integrated robotic platforms are redefining traditional protocols, enabling remote interventions, and enhancing surgeon dexterity through augmented reality and haptic feedback. With regulatory bodies increasingly recognizing the safety and efficacy of robotic interventions, the deployment of these systems is accelerating across hospitals, clinics, and specialty centers, charting a new era in clinical innovation.
Analyzing the Transformative Shifts Shaping the Healthcare Robotics Landscape with Advances in AI, Connectivity, and Regulatory Adaptations
Healthcare robotics has undergone a series of transformative shifts that extend well beyond incremental improvements. The convergence of advanced artificial intelligence and machine learning algorithms has endowed robotic platforms with predictive capabilities, enabling real-time decision support during complex procedures. Simultaneously, the proliferation of Internet of Things connectivity has fostered seamless integration between robotic units and hospital information systems, creating a data-rich ecosystem for continuous performance optimization.
Moreover, augmented reality tools are evolving from niche applications in surgical training to immersive interfaces for patient engagement and intraoperative guidance. On the policy front, evolving reimbursement models and clearer regulatory pathways have incentivized adoption by reducing financial and compliance uncertainties. Together, these shifts are redefining the competitive landscape, forcing stakeholders to reassess R&D priorities, forge novel partnerships, and recalibrate go-to-market strategies in response to a market driven by agility and collaboration.
Evaluating the Cumulative Effects of the 2025 United States Tariffs on Healthcare Robotics Procurement, Supply Chains, and Cost Structures Across the Industry
The implementation of United States tariffs in 2025 has imposed new cost pressures across the healthcare robotics supply chain, compelling manufacturers and end users to reevaluate procurement strategies. Components sourced from overseas, particularly from established technology hubs, now face elevated duties, inflating capital expenditure for advanced robotic suites and peripheral devices. In response, strategic sourcing and component localization have become critical for mitigating tariff-driven price adjustments and maintaining accessible pricing structures for healthcare providers.
These trade policies have also catalyzed innovation in logistics and inventory management, as companies seek to optimize just-in-time delivery and buffer stock levels to offset potential disruptions. As a result, cross-border alliances and regional manufacturing partnerships have accelerated, underpinning a shift toward more resilient, diversified distribution networks. Stakeholders prioritizing supply chain adaptability and transparent cost modeling will be best positioned to navigate the ongoing impact of tariff regimes on procurement cycles and capital budgeting.
Unraveling Key Segmentation Perspectives by Product, Technology, Application, and End-User with Strategic Insights into Market Dynamics
A comprehensive understanding of the healthcare robotics market demands examination through multiple segmentation lenses. When assessed by product type, diagnostic & imaging robots, noninvasive-radiosurgery robotic systems, pharmacy & laboratory robotics, rehabilitation robotic systems-further subdivided into assistive robotic systems, exoskeleton robotic systems, and therapeutic robotic systems-service & logistics robots, and surgical robots emerge as critical categories that address distinct clinical workflows and service models. This product orientation reveals precise adoption corridors and highlights areas where technological convergence is fostering new capabilities.
From a technology standpoint, artificial intelligence and machine learning form the backbone of intelligent automation, while the Internet of Things establishes interconnected platforms for device monitoring and performance analytics. Augmented reality applications, including patient engagement AR and surgical training AR, are unlocking interactive training and preoperative planning experiences. Evaluating applications across cardiology, laparoscopy, neurology, and orthopedics highlights specialized use cases driving investment in niche segments. Finally, end-user segmentation encompassing hospitals & clinics, rehabilitation centers, and surgical centers-further detailed into ambulatory surgery centers and day surgery centers-demonstrates the diverse operational settings influencing purchasing priorities and service delivery models.
Decoding Regional Variations in Healthcare Robotics Adoption and Growth across Americas, Europe Middle East Africa, and Asia-Pacific Markets
Geographic dynamics play a pivotal role in the adoption and maturation of healthcare robotics. In the Americas, advanced reimbursement frameworks and robust private-public partnerships are accelerating deployment in tertiary care and specialized surgical centers. This region’s emphasis on precision medicine and patient safety drives continued investment in integrated robotic solutions, while digital health initiatives foster interoperability and tele-robotic capabilities.
Across Europe, the Middle East, and Africa, heterogeneous regulatory environments and diverse economic conditions have shaped a multifaceted adoption curve. Western Europe’s established healthcare infrastructure sustains high uptake of surgical and diagnostic robots, whereas emerging economies in the Middle East and Africa prioritize cost-effective rehabilitation and logistics automation to address workforce deficits. In the Asia-Pacific region, proactive government policies, large patient populations, and growing domestic manufacturing capacity are fueling rapid expansion, particularly in minimally invasive surgery and rehabilitative care. These regional insights underscore the necessity for adaptable go-to-market frameworks that respect local regulations and healthcare delivery models.
Highlighting Leading Companies and Their Strategic Initiatives Driving Innovation, Partnerships, and Competitive Positioning in Healthcare Robotics
Leading companies in the healthcare robotics field are distinguishing themselves through strategic R&D investments, targeted acquisitions, and collaborative ventures. One prominent developer has leveraged its core surgical robotics platform to deliver advanced instrumentation and data analytics capabilities, establishing a singular position in high-volume operating rooms. Another diversified technology firm has integrated pharmacy automation with artificial intelligence-driven inventory management, streamlining medication dispensing and reducing manual errors.
Strategic partnerships between robotics innovators and software developers are accelerating the deployment of cloud-based control systems and predictive maintenance tools. In parallel, new entrants with expertise in exoskeleton design are forging alliances with rehabilitation centers to co-develop patient-centric solutions. This mosaic of collaboration, coupled with a focus on intellectual property expansion and clinical validation studies, is intensifying competition and shaping a landscape in which innovation speed and ecosystem integration are decisive differentiators.
Formulating Actionable Strategies and Expert Recommendations to Navigate Challenges and Capitalize on Opportunities in Healthcare Robotics
Industry leaders must pursue multifaceted strategies to harness the full potential of healthcare robotics. Prioritizing interoperability standards and open architectures will enable seamless integration of new robotic modules with existing hospital systems, minimizing implementation friction and accelerating clinical adoption. Additionally, investing in advanced workforce training programs that blend hands-on robotic operation with immersive augmented reality simulations can reduce the learning curve for surgical teams and rehabilitation specialists.
Regulatory engagement is another critical dimension: proactive collaboration with health authorities to establish clear safety guidelines and reimbursement pathways will unlock broader market access. To mitigate geopolitical and supply chain risks, companies should diversify component sourcing and explore local manufacturing partnerships, thereby enhancing supply resilience and cost predictability. Finally, forging cross-sector alliances with data analytics providers, telehealth platforms, and patient advocacy groups will expand value propositions and address evolving care delivery models, positioning stakeholders to capitalize on emerging growth opportunities.
Outline of Rigorous Research Methodology and Analytical Framework Employed to Ensure Credibility and Depth in Healthcare Robotics Market Insights
This analysis draws on a robust, multi-stage research methodology designed to ensure credibility, depth, and relevance. Initially, secondary research encompassed peer-reviewed journals, clinical trial registries, patent filings, and publicly available regulatory guidance to establish foundational context and identify prevailing technology trends. Subsequently, primary research was conducted through structured interviews with key opinion leaders, including surgeons, rehabilitation specialists, supply chain executives, and healthcare policymakers, providing firsthand perspectives on adoption drivers and constraints.
Data triangulation was applied by cross-referencing secondary sources with insights from industry participants, while top-down and bottom-up analytical techniques elucidated market and segment dynamics. Quantitative data sets were validated against real-world case studies, ensuring alignment between theoretical projections and practical implementations. This integrated approach culminates in an analytical framework that rigorously examines technological, regulatory, and operational dimensions of the healthcare robotics space.
Concluding Reflections on the Ongoing Transformation in Healthcare Robotics and the Imperative Next Steps for Industry Stakeholders to Drive Progress
The healthcare robotics industry stands at an inflection point, poised to deliver transformative benefits across surgical, diagnostic, and rehabilitative domains. Converging technological advancements in artificial intelligence, connectivity, and immersive interfaces are redefining clinical best practices, while evolving reimbursement and regulatory landscapes are lowering barriers to entry. Going forward, stakeholders must embrace collaborative innovation, supply chain agility, and workforce readiness to maintain momentum.
The path ahead will be shaped by an ongoing dialogue among manufacturers, providers, regulators, and patients, each contributing unique insights to refine safety standards, expand application scopes, and ensure equitable access. By fostering an ecosystem that balances rapid technological progress with rigorous validation and ethical considerations, industry participants can collectively drive enhanced quality of care, operational efficiency, and patient satisfaction. This conclusion underscores the importance of strategic alignment and continuous adaptation as the healthcare robotics field enters its next phase.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Product Type
Diagnostic & Imaging Robots
Noninvasive-Radiosurgery Robotic Systems
Pharmacy & Laboratory Robotics
Rehabilitation Robotic Systems
Assistive Robotic Systems
Exoskeleton Robotic Systems
Therapeutic Robotic Systems
Service & Logistics Robots
Surgical Robots
Technology
Artificial Intelligence
Augmented Reality
Patient Engagement AR
Surgical Training AR
Internet of Things (IoT)
Machine Learning
Application
Cardiology
Laparoscopy
Neurology
Orthopedics
End-User
Hospitals & Clinics
Rehabilitation Centers
Surgical Centers
Ambulatory Surgery Centers
Day Surgery Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Asensus Surgical US, Inc.
FANUC Corporation
Intuitive Surgical, Inc.
Johnson & Johnson Services, Inc.
Medtronic Plc
Parker Hannifin Corporation
Robocath SA
Siemens AG
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Adoption of AI-driven surgical robots to improve precision in minimally invasive procedures
- 5.2. Implementation of telepresence robots for continuous remote patient monitoring and care coordination
- 5.3. Deployment of robotic exoskeleton systems to accelerate mobility rehabilitation and patient independence
- 5.4. Integration of cloud connectivity and IoT sensors in surgical robotics for real-time analytics
- 5.5. Advancements in soft robotics for delicate tissue manipulation in ophthalmic microsurgery applications
- 5.6. Patient-assistive robotics delivering personalized physiotherapy routines for accelerated post-operative recovery
- 5.7. Rise of collaborative robotic pharmacy automation systems to optimize medication dispensing accuracy
- 5.8. Regulatory advancements and FDA approvals accelerating commercialization of collaborative healthcare robots
- 5.9. Integration of augmented reality interfaces in robotic surgery platforms for enhanced surgeon guidance
- 5.10. Adoption of autonomous disinfection robots in hospitals to mitigate hospital acquired infection risks
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Healthcare Robotics Market, by Product Type
- 8.1. Diagnostic & Imaging Robots
- 8.2. Noninvasive-Radiosurgery Robotic Systems
- 8.3. Pharmacy & Laboratory Robotics
- 8.4. Rehabilitation Robotic Systems
- 8.4.1. Assistive Robotic Systems
- 8.4.2. Exoskeleton Robotic Systems
- 8.4.3. Therapeutic Robotic Systems
- 8.5. Service & Logistics Robots
- 8.6. Surgical Robots
- 9. Healthcare Robotics Market, by Technology
- 9.1. Artificial Intelligence
- 9.2. Augmented Reality
- 9.2.1. Patient Engagement AR
- 9.2.2. Surgical Training AR
- 9.3. Internet of Things (IoT)
- 9.4. Machine Learning
- 10. Healthcare Robotics Market, by Application
- 10.1. Cardiology
- 10.2. Laparoscopy
- 10.3. Neurology
- 10.4. Orthopedics
- 11. Healthcare Robotics Market, by End-User
- 11.1. Hospitals & Clinics
- 11.2. Rehabilitation Centers
- 11.3. Surgical Centers
- 11.3.1. Ambulatory Surgery Centers
- 11.3.2. Day Surgery Centers
- 12. Healthcare Robotics Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Healthcare Robotics Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Healthcare Robotics Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Asensus Surgical US, Inc.
- 15.3.2. FANUC Corporation
- 15.3.3. Intuitive Surgical, Inc.
- 15.3.4. Johnson & Johnson Services, Inc.
- 15.3.5. Medtronic Plc
- 15.3.6. Parker Hannifin Corporation
- 15.3.7. Robocath SA
- 15.3.8. Siemens AG
- 15.3.9. Stryker Corporation
- 15.3.10. Zimmer Biomet Holdings, Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
